Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Foley Mark J, Director. Director active across 3 companies, notably GLAUKOS Corp. In total, 37 reports have been published. Split: 2 buys · 4 sells. Total volume traded: €2.1m. Activity tracked since 3 June 2021. The latest transaction was filed on 28 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Foley Mark J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
49,274 shares@ US$26.9714.5% of flowCommon StockSEC:0001479290-22-000087:0
25 of 37 declarations
About Foley Mark J
Mark J Foley is an administrator connected to Revance Therapeutics, Inc., GLAUKOS Corp and Zeltiq Aesthetics Inc. He has 37 filings in total, and across the recent sample of 37 filings, buys amount to EUR 649734 and sells to EUR 1432787, between 2016-01-14 and 2026-06-01, with Attribution as the most frequent transaction nature.